261 related articles for article (PubMed ID: 15944065)
1. Evaluation of the Cozart RapiScan drug test system for opiates and cocaine in oral fluid.
Cooper G; Wilson L; Reid C; Main L; Hand C
Forensic Sci Int; 2005 Jun; 150(2-3):239-43. PubMed ID: 15944065
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Cozart microplate EIA for analysis of opiates in oral fluid.
Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spiehler V
Forensic Sci Int; 2005 Nov; 154(2-3):240-6. PubMed ID: 16182972
[TBL] [Abstract][Full Text] [Related]
3. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.
Kacinko SL; Barnes AJ; Kim I; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
Forensic Sci Int; 2004 Apr; 141(1):41-8. PubMed ID: 15066713
[TBL] [Abstract][Full Text] [Related]
4. Comparison of GC-MS and EIA results for the analysis of methadone in oral fluid.
Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spiehler V
J Forensic Sci; 2005 Jul; 50(4):928-32. PubMed ID: 16078500
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Cozart Amphetamine Microplate EIA for the analysis of amphetamines in oral fluid.
Cooper G; Wilson L; Reid C; Hand C; Spiehler V
Forensic Sci Int; 2006 Jun; 159(2-3):104-12. PubMed ID: 16115742
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the Cozart RapiScan system as an on-site screening tool for drugs of abuse in a non-conventional biological matrix: vitreous humor.
Fucci N; De Giovanni N; De Giorgio F; Liddi R; Chiarotti M
Forensic Sci Int; 2006 Jan; 156(2-3):102-5. PubMed ID: 16410159
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Cozart microplate EIA for cocaine and metabolites in oral fluid.
Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spieher V
J Anal Toxicol; 2004 Sep; 28(6):498-503. PubMed ID: 15516303
[TBL] [Abstract][Full Text] [Related]
8. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
[TBL] [Abstract][Full Text] [Related]
9. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.
Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
Forensic Sci Int; 2007 Aug; 170(2-3):156-62. PubMed ID: 17658709
[TBL] [Abstract][Full Text] [Related]
10. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
[TBL] [Abstract][Full Text] [Related]
11. On-site testing of illicit drugs: the use of the drug-testing device "Toxiquick".
Biermann T; Schwarze B; Zedler B; Betz P
Forensic Sci Int; 2004 Jun; 143(1):21-5. PubMed ID: 15177627
[TBL] [Abstract][Full Text] [Related]
12. Determination of opiates and cocaine in hair using automated enzyme immunoassay screening methodologies followed by gas chromatographic-mass spectrometric (GC-MS) confirmation.
Lachenmeier K; Musshoff F; Madea B
Forensic Sci Int; 2006 Jun; 159(2-3):189-99. PubMed ID: 16203118
[TBL] [Abstract][Full Text] [Related]
13. Application of pericardial fluid to the analysis of morphine (heroin) and cocaine in forensic toxicology.
Contreras MT; Hernández AF; González M; González S; Ventura R; Pla A; Valverde JL; Segura J; de la Torre R
Forensic Sci Int; 2006 Dec; 164(2-3):168-71. PubMed ID: 16442766
[TBL] [Abstract][Full Text] [Related]
14. Cozart RapiScan Oral Fluid Drug Testing System: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administration.
Kolbrich EA; Kim I; Barnes AJ; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
J Anal Toxicol; 2003 Oct; 27(7):407-11. PubMed ID: 14606993
[TBL] [Abstract][Full Text] [Related]
15. Gas chromatography-mass spectrometry confirmation of Cozart RapiScan saliva methadone and opiates tests.
Moore L; Wicks J; Spiehler V; Holgate R
J Anal Toxicol; 2001 Oct; 25(7):520-4. PubMed ID: 11599594
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of the Cozart DDS oral fluid collection device.
Speedy T; Baldwin D; Jowett G; Gallina M; Jehanli A
Forensic Sci Int; 2007 Aug; 170(2-3):117-20. PubMed ID: 17624706
[TBL] [Abstract][Full Text] [Related]
17. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N
Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530
[TBL] [Abstract][Full Text] [Related]
18. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Cozart DDSV test for cannabis in oral fluid.
Kintz P; Brunet B; Muller JF; Serra W; Villain M; Cirimele V; Mura P
Ther Drug Monit; 2009 Feb; 31(1):131-4. PubMed ID: 19155965
[TBL] [Abstract][Full Text] [Related]
20. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results.
Crouch DJ; Cheever ML; Andrenyak DM; Kuntz DJ; Loughmiller DL
J Forensic Sci; 1998 Jan; 43(1):35-40. PubMed ID: 9456522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]